The characteristics of psychotic features in bipolar disorder.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 12 10 2018
medline: 17 7 2020
entrez: 11 10 2018
Statut: ppublish

Résumé

In a large and comprehensively assessed sample of patients with bipolar disorder type I (BDI), we investigated the prevalence of psychotic features and their relationship with life course, demographic, clinical, and cognitive characteristics. We hypothesized that groups of psychotic symptoms (Schneiderian, mood incongruent, thought disorder, delusions, and hallucinations) have distinct relations to risk factors. In a cross-sectional study of 1342 BDI patients, comprehensive demographical and clinical characteristics were assessed using the Structured Clinical Interview for DSM-IV (SCID-I) interview. In addition, levels of childhood maltreatment and intelligence quotient (IQ) were assessed. The relationships between these characteristics and psychotic symptoms were analyzed using multiple general linear models. A lifetime history of psychotic symptoms was present in 73.8% of BDI patients and included delusions in 68.9% of patients and hallucinations in 42.6%. Patients with psychotic symptoms showed a significant younger age of disease onset (β = -0.09, t = -3.38, p = 0.001) and a higher number of hospitalizations for manic episodes (F11 338 = 56.53, p < 0.001). Total IQ was comparable between groups. Patients with hallucinations had significant higher levels of childhood maltreatment (β = 0.09, t = 3.04, p = 0.002). In this large cohort of BDI patients, the vast majority of patients had experienced psychotic symptoms. Psychotic symptoms in BDI were associated with an earlier disease onset and more frequent hospitalizations particularly for manic episodes. The study emphasizes the strength of the relation between childhood maltreatment and hallucinations but did not identify distinct subgroups based on psychotic features and instead reported of a large heterogeneity of psychotic symptoms in BD.

Sections du résumé

BACKGROUND
In a large and comprehensively assessed sample of patients with bipolar disorder type I (BDI), we investigated the prevalence of psychotic features and their relationship with life course, demographic, clinical, and cognitive characteristics. We hypothesized that groups of psychotic symptoms (Schneiderian, mood incongruent, thought disorder, delusions, and hallucinations) have distinct relations to risk factors.
METHODS
In a cross-sectional study of 1342 BDI patients, comprehensive demographical and clinical characteristics were assessed using the Structured Clinical Interview for DSM-IV (SCID-I) interview. In addition, levels of childhood maltreatment and intelligence quotient (IQ) were assessed. The relationships between these characteristics and psychotic symptoms were analyzed using multiple general linear models.
RESULTS
A lifetime history of psychotic symptoms was present in 73.8% of BDI patients and included delusions in 68.9% of patients and hallucinations in 42.6%. Patients with psychotic symptoms showed a significant younger age of disease onset (β = -0.09, t = -3.38, p = 0.001) and a higher number of hospitalizations for manic episodes (F11 338 = 56.53, p < 0.001). Total IQ was comparable between groups. Patients with hallucinations had significant higher levels of childhood maltreatment (β = 0.09, t = 3.04, p = 0.002).
CONCLUSIONS
In this large cohort of BDI patients, the vast majority of patients had experienced psychotic symptoms. Psychotic symptoms in BDI were associated with an earlier disease onset and more frequent hospitalizations particularly for manic episodes. The study emphasizes the strength of the relation between childhood maltreatment and hallucinations but did not identify distinct subgroups based on psychotic features and instead reported of a large heterogeneity of psychotic symptoms in BD.

Identifiants

pubmed: 30303059
pii: S0033291718002854
doi: 10.1017/S0033291718002854
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2036-2048

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH090553
Pays : United States

Auteurs

Annet H van Bergen (AH)

Department of Psychiatry, University Medical Center Utrecht, Brain Center Rudolf Magnus, Utrecht, The Netherlands.
Department of Psychiatry, Rode Kruis Ziekenhuis, Beverwijk, The Netherlands.

Sanne Verkooijen (S)

Department of Psychiatry, University Medical Center Utrecht, Brain Center Rudolf Magnus, Utrecht, The Netherlands.

Annabel Vreeker (A)

Department of Psychiatry, University Medical Center Utrecht, Brain Center Rudolf Magnus, Utrecht, The Netherlands.

Lucija Abramovic (L)

Department of Psychiatry, University Medical Center Utrecht, Brain Center Rudolf Magnus, Utrecht, The Netherlands.

Manon H Hillegers (MH)

Department of Psychiatry, University Medical Center Utrecht, Brain Center Rudolf Magnus, Utrecht, The Netherlands.
Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands.

Annet T Spijker (AT)

Department of Mood Disorders, PsyQ, The Hague and Rotterdam, The Netherlands.

Erik Hoencamp (E)

Parnassie Group, The Hague, The Netherlands.
Insitute of Psychology Leiden University, Leiden, The Netherlands.

Eline J Regeer (EJ)

Altrecht Institute for Mental Health Care, Utrecht, The Netherlands.

Stefan E Knapen (SE)

Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Rixt F Riemersma-van der Lek (RF)

Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Robert Schoevers (R)

Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Anja W Stevens (AW)

Dimence Center for Bipolar Disorders, Almelo, The Netherlands.

Peter F J Schulte (PFJ)

Mental Health Service, Noord Holland Noord, Alkmaar, The Netherlands.

Ronald Vonk (R)

Reinier van Arkel, 's-Hertogenbosch, The Netherlands.

Rocco Hoekstra (R)

Antes, Delta Center for Mental Health Care, Rotterdam, The Netherlands.

Nico J van Beveren (NJ)

Antes, Delta Center for Mental Health Care, Rotterdam, The Netherlands.

Ralph W Kupka (RW)

Altrecht Institute for Mental Health Care, Utrecht, The Netherlands.
Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.

Iris E C Sommer (IEC)

Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Roel A Ophoff (RA)

Department of Psychiatry, University Medical Center Utrecht, Brain Center Rudolf Magnus, Utrecht, The Netherlands.
Semel Institute For Neuroscience and Human Behavior, University of California, Los Angeles, USA.

René S Kahn (RS)

Department of Psychiatry, University Medical Center Utrecht, Brain Center Rudolf Magnus, Utrecht, The Netherlands.
Department of Psychiatry, Mount Sinai School of Medicine, New York, USA.

Marco P M Boks (MPM)

Department of Psychiatry, University Medical Center Utrecht, Brain Center Rudolf Magnus, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH